Efficacy and Safety of Traditional Chinese Medicine in Idiopathic Pulmonary Fibrosis: A Meta-Analysis

被引:14
作者
Ji, Kun [1 ]
Ma, Jianling [1 ]
Wang, Liangmin [1 ]
Li, Niuniu [1 ]
Dong, Shangjuan [1 ]
Shi, Liqing [1 ]
机构
[1] Beijing Univ Tradit Chinese Med, Dongfang Hosp, Dept Resp Med, Beijing 100078, Peoples R China
基金
中国国家自然科学基金;
关键词
EPIDEMIOLOGY; SURVIVAL; TRIAL;
D O I
10.1155/2020/1752387
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. To evaluate the efficacy and safety of traditional Chinese medicine (TCM) on lung function and quality of life of idiopathic pulmonary fibrosis (IPF) patients by meta-analysis. Methods. Randomized controlled trials (RCTs) related to TCM and IPF were searched on PubMed, EMBASE Cochrane Library, ClinicalTrials, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chin VIP Information (VIP), and Chinese Biomedical Database (CBM) until December 2018. Standard mean difference (SMD) and 95% CI were calculated for the measurements related to lung function (FEV1/FVC, FVC%, FEV1%, TLC%, DLCO% or DLCO, and VC%) and other parameters (PO2, 6MWD, and SGRQ) when comparing TCM treatment to the control group. Relative risk (RR) and 95% CI of adverse events (AEs) were calculated to assess the safety of TCM. Results. A total of 40 RCTs comparing TCM to western medicine (WM) and involving 3194 IPF patients were eligible for the meta-analysis. The pooled results showed that TCM treatment improved significantly PO2 (SMD = 0.80, 95% CI 0.54 to 1.06, p < 0.001), FEV1% (SMD = 0.57, 95% CI 0.42 to 0.71, p < 0.001), DLCO% (SMD = 0.38, 95% CI 0.28 to 0.48, p < 0.001), 6MWD (SMD = 0.70, 95% CI 0.56 to 0.84, p < 0.001) and other measurements and reduced SGRQ scores (SMD = - 0.51, 95% CI - 0.70 to - 0.22, p < 0.001). Subgroup analysis of different study durations (3 months, >= 6 months) and comparison models (TCM vs. WM, TCM+ WM vs. WM or TCM vs. placebo) showed similar results. No significant difference of risk of AEs was observed between both groups (RR = 0.66, 95% CI: 0.27-1.60, p = 0.352). *ere was no obvious publication bias, and the pooled results were stable according to sensitivity analysis. Conclusion. To the best of our knowledge, the present study had the largest sample size. Our results indicated that TCM treatment may help provide benefit to the lung function, exercise capacity, and quality of life of IPF patients, alone or combined with WM, when compared to WM. More rigorous RCTs were needed in the future.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Impact of emphysema on mortality in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
    Wang, Yanhong
    Zou, Ruyi
    Yao, Yu
    Tang, Cheng
    Luo, Jing
    Lin, Minjie
    EUROPEAN JOURNAL OF INFLAMMATION, 2024, 22
  • [22] Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of an exploratory trial
    Yu, Xue-qing
    Yang, Shu-guang
    Xie, Yang
    Li, Jian-sheng
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2020, 18 (02): : 163 - 168
  • [23] Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis
    Li, Hui
    Yang, Jing
    Chen, Shanshan
    Wang, Peile
    Yu, Xueqing
    Zhou, Qingwei
    Zhang, Xiaojian
    Zhang, Guojun
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [24] Traditional Chinese medicine on treating premature ejaculation A systematic review and meta-analysis
    Li, Yongqiang
    Duan, Yunyun
    Yu, Xudong
    Wang, Jisheng
    Yao, Zeyu
    Gong, Xihao
    Gong, Xiaoyong
    Zheng, Wei
    Xue, Yahui
    Guo, Jianen
    MEDICINE, 2019, 98 (18)
  • [25] Traditional Chinese Medicine for Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Chen, Yuqing
    Zhang, Danning
    Chen, Teng
    Zhao, Lixia
    Wen, Lei
    Hou, Ruihua
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2025, 53 (01): : 1 - 15
  • [26] Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Kou, Mengjia
    Jiao, Yang
    Li, Zhipeng
    Wei, Bin
    Li, Yang
    Cai, Yaodong
    Wei, Wan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (10) : 1445 - 1460
  • [27] Effectiveness comparisons of traditional Chinese medicine for psoriasis A Bayesian network meta-analysis
    Wang, Longjun
    Tao, Yun
    Deng, Sheng
    Chu, Liyuan
    Li, Linge
    MEDICINE, 2019, 98 (36)
  • [28] Effectiveness and safety of pirfenidone for idiopathic pulmonary fibrosis
    Marcos Ribes, Borja
    Sancho-Chust, Jose N.
    Talens, Amparo
    Arlandis, Mar
    Herraiz, Paola
    Chiner, Eusebi
    Aznar, Teresa
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2020, 27 (06) : 350 - 354
  • [29] Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis
    Guo, Jianming
    Guo, Shuyan
    Dong, Siping
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [30] Efficacy and safety of prostacyclins therapy in pulmonary arterial hypertension: A meta-analysis
    Xing, Xi-Qian
    Han, Bei
    Wu, Xu-Wei
    Xiao, Yi
    Wu, Shang-Jie
    AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 5 (20): : 2199 - 2208